Physician

John R Esters, M.D.

According to 2025 Medicare claims, John Esters, M.D. (NPI: 1033390265) practices ophthalmology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is EYE CARE INSTITUTE, PA (NPI: 1629187232; TIN: 742922839) and primary practice location at 76548-1994.

Esters' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 815 traditional Medicare patients, billed 3,884 HCPCS/CPT codes, and received $254,623 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,191 prescription claims across 282 beneficiaries totaling $194,406 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 8 records totaling $280. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$167K$335K2015 Medicare payment: $237,655 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $296,211 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $287,748 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $334,788 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $290,600 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $223,163 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $266,005 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $292,539 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $231,141 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $254,623 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159413,219$237,655
20169133,167$296,211
20179613,719$287,748
20189573,982$334,788
20199063,384$290,600
20206972,377$223,163
20216952,658$266,005
20227062,747$292,539
20237303,111$231,141
20248153,884$254,623

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$100K$200K2015 Drug cost: $122,065 (USD; Tot_Drug_Cst)2016 Drug cost: $173,308 (USD; Tot_Drug_Cst)2017 Drug cost: $179,265 (USD; Tot_Drug_Cst)2018 Drug cost: $174,223 (USD; Tot_Drug_Cst)2019 Drug cost: $171,151 (USD; Tot_Drug_Cst)2020 Drug cost: $178,493 (USD; Tot_Drug_Cst)2021 Drug cost: $170,577 (USD; Tot_Drug_Cst)2022 Drug cost: $184,705 (USD; Tot_Drug_Cst)2023 Drug cost: $200,428 (USD; Tot_Drug_Cst)2024 Drug cost: $194,406 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015207998$122,065
20162271,030$173,308
20172381,099$179,265
20182371,031$174,223
2019248982$171,151
2020220982$178,493
2021221976$170,577
2022213874$184,705
2023224968$200,428
20242821,191$194,406

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more556780$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more477909$57
92083Exam of visual field with extended testing352381$39
92133Imaging of optic nerve272288$22
92250Photography of the retina309321$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine452,445$49,120
VyzultaLatanoprostene Bunod282,095$26,311
LumiganBimatoprost292,223$20,354
CombiganBrimonidine Tartrate/Timolol512,302$15,398
SimbrinzaBrinzolamide/Brimonidine Tart311,736$9,633

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$280BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John R. Esters, M.D.?

Tedicare shows public-source Medicare data for John R. Esters, M.D. (NPI 1033390265), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Esters, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John R. Esters, M.D.?

John R. Esters, M.D. is linked to EYE CARE INSTITUTE, PA (billing NPI 1629187232) in the available physician profile data.

Does John R. Esters, M.D. have Open Payments data?

John R. Esters, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.